Literature DB >> 18631846

Therapy of myasthenia gravis.

Daniel B Drachman1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18631846     DOI： 10.1016/S0072-9752(07)01508-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN： 0072-9752


× No keyword cloud information.
  4 in total

1.  Myasthenia gravis and pure red cell aplasia: a rare association.

Authors:  Riya Balikar; Neelam Narendra Redkar; Meenakshi Amit Patil; Sunil Pawar
Journal:  BMJ Case Rep       Date:  2013-02-14

2.  Pure red cell aplasia and myasthenia gravis: a patient having both autoimmune conditions in the absence of thymoma.

Authors:  Annelise Aquilina; David James Camilleri; Josanne Aquilina
Journal:  BMJ Case Rep       Date:  2017-09-11

Review 3.  Future perspectives in target-specific immunotherapies of myasthenia gravis.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

4.  Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.

Authors:  Andreas Totzeck; Elakiya Ramakrishnan; Melina Schlag; Benjamin Stolte; Kathrin Kizina; Saskia Bolz; Andreas Thimm; Mark Stettner; Julian R Marchesi; Jan Buer; Christoph Kleinschnitz; Hedda Luise Verhasselt; Tim Hagenacker
Journal:  Ther Adv Neurol Disord       Date:  2021-08-11       Impact factor: 6.570
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.